Genomics and pharmacogenomics of cluster headache: implications for personalized management? A systematic review
2024

Genetics and Treatment of Cluster Headache

Sample size: 51 publication 10 minutes Evidence: moderate

Author Information

Author(s): Isayeva Ulker, Paribello Pasquale, Ginelli Enrico, Pisanu Claudia, Comai Stefano, Carpiniello Bernardo, Squassina Alessio, Manchia Mirko

Primary Institution: University of Cagliari

Hypothesis

What are the genetic factors influencing cluster headache and their implications for personalized treatment?

Conclusion

The review highlights the complex genetic landscape of cluster headache and the need for further research to clarify genetic associations and their impact on treatment.

Supporting Evidence

  • Cluster headache is likely to have a genetic component, as shown by familial and twin studies.
  • Recent genome-wide association studies have identified new genetic risk loci for cluster headache.
  • Genetic studies have often produced inconsistent results, highlighting the need for further research.

Takeaway

Cluster headache might run in families, and scientists are trying to understand how genes affect it to help doctors treat it better.

Methodology

A systematic review of 51 studies on cluster headache genetics and pharmacogenomics, assessing quality using established scales.

Potential Biases

Potential biases due to small sample sizes and lack of statistical power in many studies.

Limitations

Many studies had small sample sizes and inconsistent results, making it hard to draw strong conclusions.

Participant Demographics

Studies included patients diagnosed with cluster headache, with a noted prevalence in men and increasing diagnoses in women.

Digital Object Identifier (DOI)

10.1097/YPG.0000000000000380

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication